Titan Medical Inc. (TMDI) News

Titan Medical Inc. (TMDI): $0.14

0.05 (-26.32%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Filter TMDI News Items

TMDI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

TMDI News Highlights

  • For TMDI, its 30 day story count is now at 3.
  • Over the past 23 days, the trend for TMDI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest TMDI News From Around the Web

Below are the latest news stories about TITAN MEDICAL INC that investors may wish to consider to help them evaluate TMDI as an investment opportunity.

Titan Medical Announces Decision of Nasdaq Hearings Panel to Delist Common Shares

Common shares to continue to trade on the Toronto Stock Exchange and are expected to trade on the OTC MarketsTORONTO, ON, March 09, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today announced that it has received a decision of the Nasdaq Hearings Panel (the “Panel”) advising the Company that effective at the open of business on March 10, 2023, the Company’s common shares will be delisted from The Nasdaq Stock Market (“Nasdaq”). On December 30,

Yahoo | March 9, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

We're starting off the day with a look at all the biggest pre-market stock movers traders need to know about on Thursday!

William White on InvestorPlace | February 23, 2023

Chapel Hill firm removes executives with latest cuts

A medical device company has laid off multiple executives as it looks to sell off assets. Titan Medical (Nasdaq: TMDI), a Canadian company with operations in Chapel Hill, has laid off four vice presidents. Titan parted ways with the executives about a week after laying off 48 employees, who were furloughed in December, at its Chapel Hill facility.

Yahoo | February 15, 2023

Titan Medical Announces Executive Leadership Updates and Receipt of Nasdaq Notification Regarding Audit Committee Requirements

Toronto, Ontario, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today announced senior leadership changes and the receipt of a notification from the Nasdaq Stock Market LLC Listing Qualifications Department stating that following the resignation of Heather Knight from the Company’s board of directors and audit committee, the Company no longer complies with Nasdaq’s audit committee requirement set forth in Nasdaq Rule 5605. Senior Leaders

Yahoo | February 14, 2023

Chapel Hill medtech laying off 48 workers as sell off looms

A medical device company in Chapel Hill is laying off most of its staff after it failed to find a buyer.

Yahoo | February 8, 2023

IIROC Trading Halt - TMD

The following issues have been halted by IIROC:

Yahoo | February 8, 2023

IIROC Trade Resumption - TMD

Trading resumes in:

Yahoo | February 8, 2023

Titan Medical Provides Corporate Update

Announces Further Costing Reduction Activities and Updates to Strategic Review ProcessTORONTO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today provided an update on the previously announced review and evaluation of strategic alternatives. As previously disclosed on November 30, 2022, Titan’s Board of Directors determined that it was in the best interests of the Company and its stakeholders to undertake a review and evaluation of stra

Yahoo | February 8, 2023

The past five years for Titan Medical (TSE:TMD) investors has not been profitable

Titan Medical Inc. ( TSE:TMD ) shareholders will doubtless be very grateful to see the share price up 95% in the last...

Yahoo | February 7, 2023

Titan Medical Shares Latest Technology Innovation and Announces Meeting Participation During J.P. Morgan Healthcare Conference Week

TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the unveiling of its next generation technology and participation in meetings to support the strategic review process announced on November 30, 2022 alongside the 41st Annual J.P. Morgan Healthcare Conference being held January 9-12 in

Yahoo | January 9, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!